Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB
暂无分享,去创建一个
A. R. Escombe | Eduardo Sanchez | Robert H Gilman | Jorge Coronel | Luz Caviedes | C. Evans | M. Hollm-Delgado | R. Gilman | D. Moore | J. Friedland | R. Oberhelman | J. Coronel | L. Caviedes | Jon S Friedland | Richard Oberhelman | David A J Moore | A Roderick Escombe | Carlton A W Evans | Aldo Vivar | Yvette Piñedo | Juan Carlos Saravia | Cayo Salazar | Maria-Graciela Hollm-Delgado | Doris LaChira | J. Saravia | Eduardo Sánchez | A. Vivar | Y. Pinedo | C. Salazar | Doris LaChira
[1] J. Palomino,et al. Evaluation of the polymerase chain reaction for the detection of Mycobacterium tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[2] M. Perkins. New diagnostic tools for tuberculosis. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[3] C. Dolea,et al. World Health Organization , 1949, International Organization.
[4] L. Collins,et al. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium , 1997, Antimicrobial agents and chemotherapy.
[5] B. Robinson-Dunn,et al. Multicenter Evaluation of Ethambutol Susceptibility Testing of Mycobacterium tuberculosis by Agar Proportion and Radiometric Methods , 2002, Journal of Clinical Microbiology.
[6] M. Patarroyo,et al. Multiprimer PCR system for differential identification of mycobacteria in clinical samples , 1996, Journal of clinical microbiology.
[7] A. R. Escombe,et al. Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting. , 2006, Diagnostic microbiology and infectious disease.
[8] T. Bodmer,et al. Multicenter Evaluation of the MB/BACT System for Susceptibility Testing of Mycobacterium tuberculosis , 2004, Journal of Clinical Microbiology.
[9] M. Lourenço,et al. Comparison of Flow Cytometric and Alamar Blue Tests with the Proportional Method for Testing Susceptibility of Mycobacterium tuberculosis to Rifampin and Isoniazid , 2004, Journal of Clinical Microbiology.
[10] M. Perkins,et al. Diagnostic testing in the control of tuberculosis. , 2002, Bulletin of the World Health Organization.
[11] A R Feinstein,et al. Use of methodological standards in diagnostic test research. Getting better but still not good. , 1995, JAMA.
[12] W. Yew,et al. Comparison of MB/BacT system and agar proportion method in drug susceptibility testing of Mycobacterium tuberculosis. , 2001, Diagnostic microbiology and infectious disease.
[13] A. Barreto,et al. Evaluation of indirect susceptibility testing of Mycobacterium tuberculosis to the first- and second-line, and alternative drugs by the newer MB/BacT system. , 2003, Memorias do Instituto Oswaldo Cruz.
[14] R. Cole,et al. Clinical evaluation of a rapid immunochromatographic assay based on the 38 kDa antigen of Mycobacterium tuberculosis on patients with pulmonary tuberculosis in China. , 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[15] R. Fontana,et al. Reliability of the MB/BacT System for Testing Susceptibility of Mycobacterium tuberculosis Complex Isolates to Antituberculous Drugs , 2000, Journal of Clinical Microbiology.
[16] David Moher,et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. , 2004, Family practice.
[17] Paul Farmer,et al. Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. , 2004, Social science & medicine.
[18] A. Feinstein,et al. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. , 1978, The New England journal of medicine.
[19] I. Khan,et al. Microplate nitrate reductase assay versus Alamar Blue assay for MIC determination of Mycobacterium tuberculosis. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[20] C B Begg,et al. Biases in the assessment of diagnostic tests. , 1987, Statistics in medicine.
[21] R. O'brien,et al. Evaluation of the MycoDot test in patients with suspected tuberculosis in a field setting in Tanzania. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[22] D. Berg,et al. Rapid, Efficient Detection and Drug Susceptibility Testing of Mycobacterium tuberculosis in Sputum by Microscopic Observation of Broth Cultures , 2000, Journal of Clinical Microbiology.
[23] Donna Neuberg,et al. Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. , 2003, The New England journal of medicine.
[24] P. Kissinger,et al. Improved Recovery of Mycobacterium tuberculosis From Children Using the Microscopic Observation Drug Susceptibility Method , 2006, Pediatrics.
[25] R. Chaisson,et al. Performance of the Microscopic Observation Drug Susceptibility Assay in Drug Susceptibility Testing for Mycobacterium tuberculosis , 2002, Journal of Clinical Microbiology.
[26] D. Rennie,et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. , 2003, Annals of internal medicine.
[27] E. Bouza,et al. Evaluation of the MB/BacT Mycobacterium Detection System for Susceptibility Testing of Mycobacterium tuberculosis , 2000, Journal of Clinical Microbiology.
[28] A. Khomenko,et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. , 2000, JAMA.
[29] M. Sakatani,et al. [A cooperative clinical study on the evaluation of an antibody detection test kit (MycoDot Test) for mycobacterial infections. Cooperative Study Group for MycoDot Test]. , 1997, Kekkaku : [Tuberculosis].
[30] C. Evans,et al. Microscopic Observation Drug Susceptibility Assay, a Rapid, Reliable Diagnostic Test for Multidrug-Resistant Tuberculosis Suitable for Use in Resource-Poor Settings , 2004, Journal of Clinical Microbiology.
[31] E. Tortoli,et al. Comparison of Mycobacterium tuberculosis susceptibility testing performed with BACTEC 460TB (Becton Dickinson) and MB/BacT (Organon Teknika) systems. , 2000, Diagnostic microbiology and infectious disease.
[32] B. Hamasur,et al. Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre. , 2001, Scandinavian journal of infectious diseases.
[33] R. McNerney,et al. Guidelines for establishing trials of new tests to diagnose tuberculosis in endemic countries. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[34] J. Bayona,et al. Identifying early treatment failure on category I therapy for pulmonary tuberculosis in Lima Ciudad, Peru. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[35] P. Fujiwara,et al. Tuberculosis bacteriology--priorities and indications in high prevalence countries: position of the technical staff of the Tuberculosis Division of the International Union Against Tuberculosis and Lung Disease. , 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[36] Robert H. Gilman,et al. Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay , 1998, Journal of Clinical Microbiology.
[37] O'Brien Rj,et al. Evaluation of the MycoDot test in patients with suspected tuberculosis in a field setting in Tanzania. , 1999 .
[38] R. Chaisson,et al. The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model , 2006, AIDS.
[39] M. Perkins,et al. More rigour needed in trials of new diagnostic agents for tuberculosis , 2000, The Lancet.